Table 2.

Primary and secondary outcomes of each ejection fraction group.

	Reduced LVEF			Normal LVEF			Hyperdynamic LVEF
	Incidence	aOR (95% CI)	p-Value	Incidence	aOR (95% CI)	p-Value	Incidence	aOR (95% CI)	p-Value
Primary outcome
60-Day mortality	22.2%	0.87 (0.44–1.65)	0.68	23.0%	Ref	–	42.6%	2.63 (1.36–5.05)	<0.01
Secondary outcomes
Severe infection	71.4%	1.02 (0.57–1.90)	0.94	70.2%	Ref	–	87.2%	2.89 (1.27–7.79)	<0.05
Intubation	47.6%	1.12 (0.65–1.94)	0.68	45.0%	Ref	–	72.3%	3.13 (1.62–6.37)	<0.01
ICU requirement	69.8%	1.02 (0.57–1.88)	0.95	68.9%	Ref	–	87.2%	3.04 (1.34–8.20)	<0.05
Pressor requirement	42.9%	0.93 (0.53–1.61)	0.79	45.0%	Ref	–	72.3%	3.11 (1.61–6.34)	<0.01

LVEF = left ventricular ejection fraction; aOR = adjusted odds ratio; CI = confidence interval.